Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483418 · ClinicalTrials.gov registry record
Survey of Testosterone Levels in Male Cancer Patients
A clinical trial, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- 425
- Enrollment target
NCT00483418 is a clinical trial that has completed, run by Beth Israel Medical Center. The registered enrollment target is 425 participants.
The verdict
NCT00483418 has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- 425 participants
- Enrollment target
Study Summary
The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and presence of opiate use for pain management, which is known to reduce testosterone levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483418
The ClinicalTrials.gov registry entry for NCT00483418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 425 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00483418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483418 about?
NCT00483418 is a clinical study titled "Survey of Testosterone Levels in Male Cancer Patients". The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and ...
What is the current status of trial NCT00483418?
This trial is currently completed. The enrollment target is 425 participants. The study started on 2007-06. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00483418?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.